RxDoctor Payments Data

Valerie McNamara, APRN

Family · Paducah, KYNPI 1306217120

Payments from drug & device makers

$8,871in general payments, 2019–2025

Across 509 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$2K
  • UCB, Inc.$1K
  • Johnson & Johnson$756
  • Novartis$445
  • Pfizer$420
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$8,72298%
  • Education$1492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,871 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$510,552
Medicare patients
680
Services billed
37,753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept35$259,565
Humira(Cf) PenAdalimumab11$209,979
RinvoqUpadacitinib32$209,584
Orencia ClickjectAbatacept16$90,230
SavellaMilnacipran Hcl12$14,419
Hydroxychloroquine Sulfate288$9,025
MethotrexateMethotrexate Sodium297$6,262
Leflunomide103$4,690
Colchicine39$3,358
Celecoxib104$2,589
Prednisone316$1,815
Duloxetine Hcl146$1,490
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol11$1,425
Cevimeline Hcl13$1,283
Sulfasalazine DrSulfasalazine34$1,001

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Savella$1,749$224,00344 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.

Other family in Paducah

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →